HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
28 hedge funds and large institutions have $5.13M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
24% less capital invested
Capital invested by funds: $6.79M → $5.13M (-$1.66M)
Holders
28
Holding in Top 10
–
Calls
$5K
Puts
$1K
Top Buyers
| 1 | +$466K | |
| 2 | +$398K | |
| 3 | +$317K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$170K |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$124K |
Top Sellers
| 1 | -$121K | |
| 2 | -$106K | |
| 3 | -$27K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$27K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$15K |